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 Background: Emotion regulation has been identified as a major contributor to the 
development of psychopathology and, by extension, to understanding the positive effects of 
various psychotherapy mechanisms. Little work has been done, however, on the extent to which 
individual components of emotion regulation operate as prognostic factors in psychological 
treatment. Context sensitivity and reflective functioning are emerging as important aspects of 
adaptive emotion regulation capacity and may be related to a portion of patient therapy outcome 
when investigated as a patient characteristic.  
Design and Participants: A sample of 130 adults seeking treatment for depression and anxiety 
through a digital psychotherapy provider were recruited to participate. Individuals presenting 
with comorbid severe mental illness or psychosis, significant substance abuse concerns, active 
suicidal ideation, and active manic states were excluded from participation.  
Methods: Participants completed individual difference measures for Five-factor Personality, 
reflective functioning (i.e., Reflective Functioning Questionnaire; RFQ), and the context 
sensitivity (i.e., Context Sensitivity Index; CSI), and were followed over three months of 
psychotherapy. Clinical outcomes were measured with diagnosis-specific symptom measures 
 
 
such as the PHQ-9 for depression and the GAD-7 for anxiety at baseline and then every 3 weeks 
for the duration of treatment.  
Results: Participants reported significant improvement in depression and anxiety symptoms after 
three months of treatment (p < .001). CSI and RFQ scores were unassociated with baseline 
symptom severity. Certainty about others’ thoughts, an RFQ subscale, was inversely associated 
with outcome (p < .05). CSI scores were unassociated with treatment outcome at 3 months. Lack 
of insight, an RFQ subscale, significantly improved as a result of treatment when baseline 
symptoms were high (p < .05).  
Conclusions: Reflective functioning may be a promising patient characteristic for explaining a 
modest portion of treatment outcome. Lack of emotional insight improved meaningfully as a 
result of treatment for individuals with more severe depression and anxiety at baseline. Further 
research is needed to investigate aspects of emotion regulation as a route towards better 
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 In response to early criticism (Eysenck, 1952), research on psychotherapy over 
the last half century has demonstrated consistent and robust effects in alleviating a wide variety 
of disorders from the so-called common disorders of anxiety (Cuijpers et al., 2014, 2016) and 
depression (Barth et al., 2016; Mohr et al., 2014), to others such as obsessive-compulsive 
disorder (OCD; Olatunji et al., 2013), eating disorders (Godfrey et al., 2015), personality 
disorders (Cristea et al., 2017), and severe conditions like bipolar disorder (Chatterton et al., 
2017; Oud et al., 2016) and psychosis (Velthorst et al., 2015). The research demonstrating these 
effects has largely derived from efficacy or randomized clinical (or controlled) trials (RCTs), but 
longitudinal, effectiveness study designs that privilege the way therapy is conducted in practice 
have also demonstrated the salubrious effects of treatment (de Jong & DeRubeis, 2018; Nathan, 
Stuart, & Dolan, 2000). While helpful for determining the overall impact of psychotherapy, these 
results cannot identify the specific factors associated with the change experienced by patients 
between the beginning of therapy and its termination. Investigating this question requires 
differentiating the effects of the therapy itself from other important factors such as the 
characteristics of the patient, the characteristics of the therapist, the relationship they establish 
with each other, and other factors common to all forms of psychotherapy. 
The effects of each of these factors have been indirectly estimated, but few have been 
targeted either experimentally through randomization, or observationally using individual 
difference measures. Indirect estimates have suggested that patient characteristics in particular 
account for a large amount of variance in psychotherapy outcomes and could be the most 
promising avenue for explaining the effects of psychotherapy. Recent advances in emotion 
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regulation as a patient characteristic offer theoretical and operational resources for understanding 
the genesis and maintenance of various forms of psychopathology (Kring & Sloan, 2009), 
especially depression and anxiety (Mennin, Heimberg, Turk, & Fresco, 2005; Rottenberg, Gross, 
& Gotlib, 2005) and could be an important patient characteristic for understanding therapy 
outcomes. One particularly promising development in the emotion regulation literature pertains 
to the concept of regulatory flexibility (Bonanno & Burton, 2013), which highlights the ability to 
perceive and respond to the demands and opportunities imposed by emotionally triggering or 
stressful contexts. This individual differences paradigm proposes a number of components 
thought to impact emotion regulation and the course of psychopathology. These include a 
person’s sensitivity to the demands and opportunities of a situation the person is in (i.e., context 
sensitivity), followed by their ability to deploy a regulation strategy from among their repertoire 
suitable to that situation, and finally their ability to register and respond to feedback on how well 
the strategy worked in that situation. Context sensitivity is the ability to perceive the presence 
and absence of important cues in a situation, and since it is the first step in the self-regulation 
process, it will be the primary focus of this investigation. Another potentially impactful 
individual difference theorized within regulatory flexibility is the ability of the person to 
understand the psychological states of others within the context of their own emotional states. 
This is an important backdrop for reflection on and flexibility within situations where emotion 
regulation is needed (Fonagy et al., 2016), and is here investigated in parallel with and as 
potentially related to context sensitivity. Finally, five-factor personality traits (McRae & Costa, 
1996) offer a general and well-established individual difference framework with several factors 
related to emotion regulation. While of secondary interest, the five factors will be useful in 
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differentiating more domain general patient characteristics (the five factors) from more domain 
specific characteristics like emotion regulation. 
Patient Characteristics in Psychotherapy 
Research to isolate the various factors of change in psychotherapy has identified five 
sources of therapy effects that include 1) common factors, 2) expectation and placebo, 3) specific 
factors, 4) patient characteristics, and 5) therapist characteristics (Wampold, 2001, 2015; 
Wampold & Imel, 2015). Common factors include the therapeutic alliance and relational bond 
with the therapist that are important to every type of psychotherapy. Expectation and placebo 
capture the patient’s investment in and hope for positive outcomes from the therapy. The specific 
factors are the particular interventions theorized to drive clinical change and that distinguish 
different therapy approaches from each other (e.g., cognitive restructuring in Beckian CBT vs. 
exploration of fantasy in psychodynamic psychotherapy). Patient and therapist characteristics are 
often considered to be “extratherapeutic” factors that have a significant impact on outcome but 
that are not directly controllable by the treatment setting. These five sources each account for 
different degrees of variance in outcome.  
An early estimate (Lambert, 1992) of the relative contribution of each of these factors 
attributed 30% of outcome to common factors, 15% to specific factors, 15% to expectation 
effects, and 40% to extratherapy factors and therapist/patient characteristics. While suggestive, 
these allocations were based on the author’s impressions from the literature and lacked any direct 
empirical evidence. A recent meta-analysis (Cuijpers et al., 2012) sought to more firmly establish 
these estimates by isolating improvements from 1) within control conditions (to quantify 
extratherapy and expectation factors), 2) across multiple treatment arms (to quantify common 
factors), and 3) from superior effects of carefully operationalized treatments over supportive 
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counseling (to quantify specific factors). Under this approach, extratherapeutic and expectation 
factors were responsible for 33.3% of outcome, common factors for 49.6% of outcome, and 
specific factors for 17.1% of outcome. While there continues to be a lot of research on and 
debate over what counts as a common factor versus what counts as a specific factor, as well as 
on specific treatment packages and the effect of placebo, comparatively little has been done to 
investigate extratherapy factors, even though they account for a large proportion of outcome.  
There could be a number of reasons for this. One is that the focus on techniques and 
packages tends to treat other sources of improvement as nuisance variables that are either 
controlled statistically or through randomization. Another is the practicality of obtaining 
sufficiently large samples of patients for whom outcome data and individual difference measures 
exist in one data set. Recruiting subjects for treatment studies while overcoming obstacles of 
dropout and assessment completion is challenging enough without adding additional measures. 
One way to work around these challenges is through recent developments in digital mental 
health. These platforms deliver therapy through modern communication technologies, are 
gaining in popularity, and have advantages for patient recruitment and data capture that 
traditional face-to-face settings typically lack. The accessibility and convenience of smartphones 
and other mobile devices allow therapists to reach people who would otherwise be excluded due 
to geographic distance or scheduling conflicts. The malleability of the digital interface between 
therapist and patient also makes it easier for researchers to present assessments as a seamless part 
of the patient’s experience to facilitate assessment completion. The combination of increased 
accessibility and malleability makes digital health platforms a promising medium for 
investigating historically intractable research questions.  
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 While data capture and rapid recruitment on digital platforms provides a solution to past 
research barriers, there are certainly differences in how care is delivered and received on these 
platforms that may limit the generalizability of the findings to all therapy settings. This issue is 
discussed first, followed by the overview of a promising individual differences paradigm.  
The Potential of Digital Psychotherapy 
Despite the large volume of research supporting psychotherapeutic treatment, the 
majority of adults experiencing psychiatric disorders do not obtain face-to-face treatment due to 
barriers in accessing mental health care (Young, Klapp, Sherbourne & Wells, 2001; Brody, 
Khaliq & Thompson, 1997). Significant barriers to care can occur at several levels (Scheppers, 
Dongen, Dekker, Geertzen & Dekker, 2006) and include issues such as geographic remoteness, 
economic or insurance constraints, shortage of practitioners, stigmatization, and physical 
impairment (Alleman, 2002; Fjeldsoe, Marshall, & Miller, 2009; Hollon et al., 2002; Nutting et 
al., 2002; Young, 2005). These barriers lead to insufficient treatment access, particularly in 
underserved populations, highlighting the need of innovative mechanisms to enhance treatment 
delivery (Comer & Barlow, 2014; Mohr et al., 2006). 
Technology-based delivery of treatment has become increasingly popular in recent years. 
Telemedicine interventions may be uniquely positioned to mitigate inequalities of access to care 
by reducing wait times and increasing accessibility through overcoming geographic and mobility 
barriers. A number of studies have identified contexts in which therapy delivered via technology 
platforms can be effective in reducing symptoms across a range of psychiatric diagnoses (Bee et 
al., 2008; Hull & Mahan, 2017; Kessler, et al., 2009; Nelson, Barnard, & Cain, 2003; Reynolds, 
Stiles & Grohl, 2006). For example, a meta-analytic review of thirteen studies examining the 
effectiveness of psychotherapeutic interventions delivered by telephone, internet and 
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videoconference, identified a medium pooled effect size of .44 for those with depression, and a 
large pooled effect size of 1.15 for those with anxiety disorders (Bee et al., 2008).  
Research on technology-mediated treatment has largely been conducted with respect to its most 
common synchronous medium, live video. Newer forms of synchronous and asynchronous 
delivery, such as Multimedia message services (MMS) or “texting,” have so far received much 
less attention as a form for delivering direct clinical care, but are promising given the wide 
availability of texting platforms. MMS has been effectively used in the past as an adjunct to 
clinical care, occupying the role of a reminder system or symptom tracker focusing on promoting 
healthy lifestyle behavior and medication adherence (Fjeldsoe, Marshall, & Miller, 2009; 
Militello, Kelly, & Melnyk, 2012). Synchronous MMS, or “live chat,” has been used to directly 
deliver psychotherapy and was shown to be effective in improving symptom remission when 
combined with a primary care provider (Kessler et al., 2009). The next generation of MMS has 
piloted asynchronous modes for delivering care in an attempt to simplify scheduling barriers and 
expedite the beginning of treatment. In this approach, patients are free to message their provider 
whenever they like 24/7, and clinicians respond during pre-identified times each day for at least 
five days a week. Preliminary evidence suggests that this approach is an acceptable and 
potentially effective medium for delivering therapeutic interventions (Hull & Mahan, 2017).  
Ongoing research on the use of asynchronous MMS messaging therapy in treating 
specific diagnostic types continues to bear out its utility as a broadly effective and acceptable 
form of delivering care. Longitudinal effectiveness studies on depression and anxiety (Hull, 
Malgaroli, Connolly, Feuerstein, & Simon, 2020) and on PTSD (Malgaroli, Hull, Wiltsey-
Stirman, & Resick, 2020) have shown that between 48% and 53% of treatment seeking patients 
experience clinically significant change, with another 15% to 20% showing marked, reliable 
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improvement. Latent growth mixture models of these patient populations have identified that 
patient characteristics such as gender, age, and readiness for treatment are important in 
accounting for symptom reduction and treatment success. Similar to face-to-face treatment, 
measures of the therapeutic alliance have also been shown to predict outcomes for messaging 
therapy (Hull & Mahan, 2017; Malgaroli, Hull, Wiltsey-Stirman, & Resick, 2020). These 
findings so far suggest that differences in therapy change mechanisms, if any, between 
traditional face-to-face settings and digital mental health settings have had little impact on 
treatment success. Thus there is reason to expect that patient characteristics, especially from the 
perspective of emotion regulation, are important for psychotherapy regardless of the delivery 
medium employed. The next section suggests an important role for individual differences in 
emotion regulation as part of the basis for and maintenance of psychopathology. Regulatory 
flexibility is highlighted as a particular framework for investigating the role of emotion 
regulation as an informative patient characteristic in psychotherapy. 
Regulatory Flexibility 
Individual differences in emotion regulation have been implicated in the development of 
psychopathology (Buss, Davidson, Kalin, & Goldsmith, 2004; Gerhicke, & Shapiro, 2000; Kring 
& Sloan, 2009). These differences can be identified across several aspects of emotional 
experience and control. Recent research has pointed to the importance of the ability to 
understand and perceive the demands and opportunities imposed by emotionally triggering or 
stressful contexts, a concept referred to as context sensitivity (Bonanno & Burton, 2013). When 
emotions are expressed without regard for specific elements of contextual demands, negative 
outcomes associated with psychopathology, including depression, mania, and grief (Bonanno et 
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al., 2007; Gruber, Johnson, Oveis, & Keltner, 2008; Rottenberg & Gotlib, 2004; Rottenberg, 
Gross & Gotlib, 2005) are more likely. 
For example, individuals with depression exhibit signs of inflexible emotional responses, 
primarily blunted expressions regardless of the demands of the environment (Rottenberg, Kasch, 
Gross, & Gotlib, 2002). Deficits have also been indicated in samples with generalized anxiety 
where elevations in expressivity of negative emotion in comparison to healthy controls have 
been identified (Mennin, Heimberg, Turk, & Fresco, 2005). Atypical responding to contextual 
factors and emotional expressions of others has also been associated with a number of 
psychological disorders and has been connected to impairments in socialization and 
communication, increased aggressive behaviors, the inability to modulate behavior according to 
the social context, or even a failure to avoid actions that cause harm to others (Penton-Voak et 
al., 2013). 
Conversely, the ability to flexibly regulate emotional reactions based on features of the 
immediate context has been associated with well-being and behavioral adjustment (Bonanno, 
Papa, Lalande, Westphal, & Coifman, 2004; Bonanno, Pat-Horenczyk, & Noll, 2011; Bonanno 
et al., 2007; Levy-Gigi et al., 2015; Troy, Shallcross, & Mauss, 2013).  Bonanno and Burton 
(2013) have theorized three general sets of abilities that give rise to regulatory flexibility. The 
first, sensitivity to context, is an important first step towards flexible regulation because 
emotions confer an advantage only when deployed in appropriate situations. Second, having a 
broad repertoire of emotion regulation strategies is critical to addressing the specific and highly 
variable demands of the situation. Finally, one’s perception of the context may not always be 
accurate, or one’s regulatory repertoire may not be sufficient, such that the ability to monitor the 
effectiveness of emotion regulation efforts and respond to feedback is vital (see Sheppes, Suri, & 
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Gross, 2015 for a complimentary approach). Research to date has demonstrated that context 
insensitivity (Coifman & Bonanno, 2010), and a narrow and inflexible repertoire of regulation 
strategies (Troy et al., 2013), are associated with poor adjustment and well-being. 
As a set of cognitive and social skills that kick off any emotion-related event, context 
sensitivity stands out among the aspects of regulatory flexibility as an individual difference that 
is particularly promising for predicting baseline severity of psychopathology as well as response 
to psychotherapy.  
Context Sensitivity and the Context Sensitivity Index 
It is a generally accepted principle of emotion theory (Lewis, Haviland-Jones, & Barrett, 
2010), and of frameworks of action broadly (Carver & Scheier, 2008), that the way we respond 
to situations is context bound. When emotions are expressed in inappropriate contexts, or when 
expressions and actions go beyond the bounds of the context, this constitutes context-insensitive 
emotional responding, and has been tied to psychopathology including depression, anxiety, 
mania, and prolonged grief (Bonanno et al., 2007; Gruber, Johnson, Oveis, & Keltner, 2008; 
Rottenberg & Gotlib, 2004; Rottenberg, Gross & Gotlib, 2005).  
Context-sensitive responding, on the other hand, involves the ability to shift emotion 
responses, such as facial expressions, speech, and other bodily actions, in accordance with the 
demands and opportunities of the context and has been associated with positive adjustment 
(Aldao, 2013; Bonanno & Burton, 2013; Rottenberg, Gross, & Gotlib, 2005). Various forms of 
psychopathology can be considered disorders involving emotion context-insensitivity, or a 
persistent mismatch between the emotion expressed and the context. For example, fear is 
generally normative and useful, however when expressed repeatedly by an individual with PTSD 
in a safe setting or at an inappropriate time, it can become pathogenic (Davidson, Jackson, & 
10 
 
Kalin, 2000). For those experiencing grief, feelings of sadness or guilt are natural and expected, 
but the prolonged and continuous expression of sadness or guilt regardless of what the context 
demands tends to lead to difficulties adjusting to the loss.  
It has been theorized, and data suggests, that context insensitivity is derived from 
individual differences in the ability to read contextual cues and to identify when important 
information is misleading or missing (Bonanno, Maccallum, Malgaroli, & Hou, 2020). This 
work further specifies that context sensitivity be broken down into subsets of abilities such as 
being able to tell how much control one has over a situation, how much control others have over 
a situation, how threatening a situation is, and the urgency to react to a situation. Importantly, 
research suggests that there are significant individual differences in these abilities (Bonanno, 
Maccallum, Malgaroli, & Hou, 2020; Cheng, Chiu, Hong, & Cheung, 2001; Coifman & 
Bonanno, 2010), which highlighted the need for a standardized measure to capture these 
differences that can be broadly administered and that is distinct to context sensitivity.  
The Context Sensitivity Index (CSI; Bonanno, Maccallum, Malgaroli, & Hou, 2020) was 
developed to address several gaps in the literature on context and self-regulation. First, it sought 
to overcome the limitations of emotion-evoking films and interview tasks by separating the 
perception of contextual cues from the response to these cues. Second, it was designed to be 
completed by individuals without having to come into a lab to ease administrative burden. Third, 
it relied on standardized hypothetical scenarios to minimize recall bias and to minimize reliance 
on an individual’s self-insight regarding context sensitivity, which are typical problems for self-
report questionnaires (Schwartz, Neale, Marco, Shiffman, & Stone, 1999). Finally, items sought 
to measure a person’s sensitivity to the contextual cues that are present, as well as their ability to 
determine when important cues are absent. Five studies have helped to establish the measure’s 
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validity and reliability to assess context sensitivity (Bonanno, Maccallum, Malgaroli, & Hou, 
2020) across six different scenarios. Results supported the separation of Cue Presence and Cue 
Absence subscales, each of which exhibited associations with different classes of variables. For 
example, whereas the Cue Presence scale was associated with measures of flexibility and context 
perception, the Cue Absence scale was associated with measures of stress, depression and 
anxiety symptoms. The CSI is thus an important addition to research on regulatory flexibility and 
highlights its usefulness as a tool for assessing individual differences and patient characteristics 
for psychotherapy outcome research and psychopathology. 
Reflective Functioning and the Five-Factor Model 
 As discussed, the CSI presents individuals with scenarios eliciting their judgments to 
establish the extent to which they are responding to cues in a given situation. An important 
corollary to their performance on this task is the extent to which individuals self-report 
sensitivity to the actions of others and their own feelings across contexts in their daily lives. The 
Reflective Functioning Questionnaire (RFQ) was designed to assess the degree to which 
individuals make assumptions about the goals and desires of other people (a subscale termed 
hypermentalization), as well as the extent to which individuals lack insight into their feelings (a 
subscale termed hypomentalization). Previous research has shown that RFQ scores predict 
symptom severity and that the measure demonstrates good convergent and discriminant validity 
with associations to measures of empathy and perspective-taking (Fonagy et al., 2016). This 
work has shown that the two subscales, hypomentalization and hypermentalization, are 
associated differently with the clinical presentation of those studied. Hypomentalization reflects 
deficits in a person’s ability to be aware of their emotional experiences and have insight into 
their feelings. Hypermentalization is a state in which a person projects beliefs and desires onto 
12 
 
others that the other people do not have and to maintain certainty about their assumptions even in 
the face of contradictory behavior or other evidence. Hypomentalization was particularly 
associated with measures of depression and anxiety symptoms, whereas hypermentalization was 
most associated with relational volatility and conflict with others. However, the measure has 
only been used diagnostically to date and has not been studied as an aspect of treatment outcome, 
which will be a novel application of the measure in this study. The RFQ will also be investigated 
as a convergent, but separable aspect of context sensitivity that captures a person’s understanding 
of how they identify cues from others (i.e. hypermentalization) and how they identify cues from 
themselves (i.e., hypomentalization). 
 A final approach to individual differences is the five-factor model of personality (McRae 
& Costa, 1996). This model has been studied in an extremely large number of contexts, including 
psychotherapy (see Bucher, Suzuki, & Samuel, 2019 for a review), and has been shown to 
generally be associated with many areas of human functioning. For this reason, including it as a 
more domain-general measure of personality alongside measures more specific to emotion 
regulation expands the types of patient characteristics investigated in the context of 
psychotherapy. While its association with variables of interest in psychotherapy research is 
modest, the five-factor model has been found to be a rate limiting factor on improvement 
(Zinbarg, Uliaszek, & Adler, 2008), as a predictor of whether someone will benefit more from 
pharmacotherapy versus psychotherapy (Bagby, Quilty, & Ryder, 2008), and as a moderator of 
the therapeutic alliance (Bucher, Suzuki, & Samuel, 2019). Extraversion, conscientiousness and 
openness tend to predict better therapy outcomes, whereas neuroticism runs counter to successful 
treatment (Bucher, Suzuki, & Samuel, 2019). The relationship between any of the five factors 






The Current Study 
The current study seeks to address the lack of research on patient characteristics as an 
important aspect of psychotherapy outcomes by measuring the context sensitivity of treatment 
seeking adults using individual difference assessments on a digital mental health platform that 
include the CSI, RFQ, and five-factor model. The relationship between individual difference 
scores and baseline symptom severity for depression and anxiety, as well as the relationship 
between individual difference scores and improvement in symptom scores over the duration of 
treatment were investigated. Another important question is the extent to which treatment leads to 
changes in individual differences. This was investigated by administering the CSI and RFQ at 
both the beginning and end of treatment.  
Although neither the RFQ nor CSI have been investigated within the context of therapy 
outcomes, we offer some hypotheses regarding the extent to which individual difference 
variables will change as a result of therapy. The CSI reports on two subscales, Cue Absence and 
Cue Presence, which reflect the individual’s ability to sense whether important cues are present 
or absent. Previous work suggests that Cue Absence, especially, is lower in individuals with 
depression and anxiety (Bonanno, Maccallum, Malgaroli, & Hou, 2020), and it is possible that 
Cue Absence will evidence the most improvement in successful therapies. The RFQ is similarly 
composed of two subscales, hypomentalization and hypermentalization, which correspond to 
lack of emotional insight and lack of social insight respectively. Here it is anticipated that 
hypomentalization will see the most improvement as a result of therapy given that low scores on 
this scale are associated with a wide variety of disorders (Fonagy et al., 2016), whereas the 
hypermentalization scale most accurately distinguishes individuals with severe pathology, such 
as Borderline Personality Disorder. Since this sample is composed of individuals with depression 
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and anxiety disorders, we expect little variation and little improvement in hypermentalization 
scores. The relationship between both Cue Absence and hypomentalization with depression and 
anxiety symptoms suggests they may bear a relationship to each other as well, though 
theoretically they are dissociable concepts. Research on the Cue Presence scale of the CSI 
demonstrated a relationship between Cue Presence and other measures of context sensitivity and 
flexibility (Bonanno, Maccallum, Malgaroli, & Hou, 2020). Insofar as hypermentalization is a 
weakness in reading social cues, Cue Presence may be inversely related to hypermentalization 
scores.  
Regarding the five-factor model, although five-factor traits typically do not change much 
over time, some research has found slight increases in certain factors as a result of therapy 
(Bleidorn et al, 2019). Since several studies have already investigated five-factor change through 
therapy, and since the measure is by far the longest of those given, a second five-factor 
administration will not be offered to the participants. As a result, change in any of the five 
factors was not investigated here. 
In summary, we hypothesize the following: 
1. Higher scores on the CSI and specific personality dimensions (i.e., extraversion, 
conscientiousness, and openness) will be associated with lower baseline symptom 
severity. Lower scores on the RFQ will be associated with lower baseline symptom 
severity. 
a. We expect higher CSI scores and lower RFQ scores to predict lower baseline 
symptoms 
b. The Cue Absence subscale of the CSI is predicted to be more strongly associated 
with baseline symptoms than the Cue Presence subscale 
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c. The Hypomentalization subscale of the RFQ is predicted to be more strongly 
associated with baseline symptoms than the Hypermentalization subscale 
2. Higher CSI, lower RFQ, and higher personality scores are expected to be associated with 
greater symptom improvement overall.  
a. We expect higher CSI and lower RFQ scores to predict greater symptom 
improvement  
b. Both the Cue Absence and Cue Presence subscales of the CSI are predicted to be 
associated with symptom improvement since both reflect skills that would likely 
enable a patient to derive benefit from therapy and transfer these benefits to other 
contexts 
c. The Hypomentalization subscale of the RFQ is predicted to be more strongly 
associated with improvement than the Hypermentalization subscale, primarily 
because we do not expect a lot of variance in hypermentalization scores for a 
sample with depression and anxiety 
3. Greater symptom improvement is expected to be associated with increases in CSI scores 
and decreases in RFQ scores. Improvements in personality scores from therapy have 
already been documented (Bleidorn et al, 2019) and are not investigated here.  
a. Symptom improvement will be more strongly associated with increases in the Cue 
Absence subscale than the Cue Presence subscale, give the association between 
Cue Absence and symptom ratings in previous work 
b. Symptom improvement will be more strongly associated with decreases in the 
Hypomentalization subscale of the RFQ than the Hypermentalization subscale 
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4. We expect a complementary association between the CSI and RFQ indices, supporting 
the notion that both are related to abilities to identify important cues from self and others. 
Associations are expected to weak however, given that the CSI is a performative 
measure, whereas the RFQ is a self report measure.   
a. Cue Absence and Hypomentalization, while theoretically distinct, are predicted to 
be modestly associated given their relationship to anxiety and depression 
symptom scores 
5. We made no specific hypotheses about the relationship between the five-factor model and 










The study was conducted with a digital mental health platform (Talkspace) used by 
independently practicing, licensed therapists in the United States. The platform is accessible 
through internet search, through Employee Assistance Programs, and as a behavioral health 
benefit through several individual insurance plans. Patients first meet with an intake clinician 
through a live messaging system to conduct a brief, standardized intake to identify the presenting 
complaint, patient treatment history, and the patient’s provider preferences. This information 
informs a matching algorithm that prioritizes and presents three providers with the desired 
characteristics for the patient to choose among. Once a clinician is chosen, the provider is 
alerted, and the patient is immediately introduced to the messaging “room” where treatment 
takes place. Patients complete a self-report baseline assessment and the provider walks them 
through the informed consent and emergency contact process after which treatment can begin. 
Observations in this study include data collected as part of organizational quality assurance and 
program management processes between March 11, 2020 and June 17, 2020. All patients and 
clinicians gave written consent to the use of their data in a de-identified, aggregate format as part 
of the user agreement before they began using the platform. Study procedures were approved as 
exempt by the institutional review board at Teachers College, Columbia University (20-412).  
Participants 
Patients 
Participants were individuals who presented with a chief complaint of anxiety or 
depression, were seeking treatment through the service, and who completed at least one PHQ-9 
and/or GAD-7. Inclusion criteria consisted of: (1) being English speakers in the United States, 
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(2) between the ages of 18 and 65, (3) having regular internet or cellphone access, (4) receiving a 
depression or anxiety diagnosis from their assigned licensed mental health provider based on a 
clinical intake and live messaging or video-based interview, as recorded in the electronic medical 
record with ICD-10 codes, (5) scoring 10 or higher on the PHQ-9 and/or GAD-7. Exclusion 
criteria consisted of current or past diagnoses of: (1) bipolar disorder, (2) any schizophrenia 
spectrum and psychotic disorder, or psychotic features, (3) any medical or neurological condition 
that would better account for the symptoms, (4) substance or alcohol use disorder (5) any 
condition requiring hospitalization; or (6) suicidal thoughts and/or behavior sufficient to be 
marked a “Yes” on any of questions three through six (at least thoughts about a potential suicide 
method), on the Columbia Suicide Severity Rating Scale Lifetime-Recent Screen (Oquendo, 
Halberstam, & Mann, 2003), requiring a more intensive level of care that interrupted treatment 
on the platform. Patients meeting the above criteria and who had scores for the CSI, RFQ and 
five-factor measures were included. 
Clinicians 
 Clinicians in the provider network were currently licensed in one or more states, were 
required to have at least a Masters degree, and had at least three years of post-licensure 
experience delivering mental health care. Clinicians were matched only to patients where 
licensure included the patient’s residence. There were a total of 17 clinicians – 45% of whom 
reported five to nine years of post-licensure experience, and 37.5% reporting ten or more years 
of experience. Ninety-one percent (91%) were female. Providers had a mean age of 40 (SD = 
9.4) years, and they reported a mix of orientations as part of their provider profile: 66% 





 Clinicians and patients asynchronously exchanged text-, audio-, and video-based 
messages using a secure, HIPAA-compliant platform accessible on mobile devices and on 
desktop computers. Patients could freely send messages at any time without limit, and all 
messages were stored for the clinician when they returned to review the message history.  
Therapists responded to messages from their patients at least once a day, five days a week. 
Clinicians were expected to adhere to all reporting, professional, and ethical standards for their 
respective fields, and appropriate referrals were provided for patients judged to need a higher 
level of care.  
The number of words exchanged between therapists and patients is automatically counted 
as meta-data by the platform, and was used as a proxy to quantify the extent of therapeutic 
interaction through the asynchronous messaging medium. Raw counts of words sent by 




Patients were assessed for depression and anxiety symptoms at baseline and then every 
three weeks for the duration of treatment, or until the patient opted to stop receiving assessments. 
Assessments are introduced to patients as an important aspect of their care that facilitates goal 
setting and to track progress. In this study, five assessments from baseline to week 12 were 
analyzed, including: Baseline, Week 3, Week 6, Week 9, and Week 12. 
The 9-item Patient Health Questionnaire (Kroenke & Spitzer, 2002) was used to identify 
the clinical severity of depression. Responses on all items were given on a 4-point Likert scale (0 
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=Not at all to 3 = Nearly every day) with a total maximum score of 27. Scores greater or equal 
than 10 have been shown to have high sensitivity and specificity as a threshold for clinical 
depression, or at least moderate depression (Kroenke, Spitzer, & Williams, 2001; Kroenke et al., 
2001). 
Anxiety symptoms were assessed with the 7-item Generalized Anxiety Disorder 
questionnaire (Spitzer et al., 2006). Responses on all items were given on a 4-point Likert scale 
(0 =Not at all to 3 = Nearly every day) with a total maximum score of 21. Scores of 10 or above 
have been shown having high sensitivity and specificity as a clinically significant threshold for at 
least moderate anxiety (Kroenke et al., 2007). 
The CSI presents six scenarios of plausible everyday events and asks respondents to 
complete three to four questions for each scenario on a 7-point Likert scale (1 = None/Not at all 
to 7 = Very Much/Extremely) that gauge the respondents’ sense of the controllability, urgency, 
threatening feeling, and cooperation potential in the situation (Bonanno, Maccallum, Malgaroli, 
& Hou, 2018). The measure totals 20 items. Ten items contribute to the subscale for Cue 
Presence with a minimum score of 10 and maximum score of 70. The other ten items map onto 
the Cue Absence subscale, are reverse coded, and have a minimum score of 10 and maximum of 
70. An example scenario is “A friend calls and asks you to do a favor for their partner, whom 
you don’t like.” A Cue Presence prompt for this scenario is “How much control do you have 
over what happens next?” and a Cue Absence prompt is “How threatening is this situation?” 
The RFQ is an 8-item survey that measures reflective functioning or mentalization with 
two subscales, hypermentalization and hypomentalization (Fonagy et al, 2016). Each item is 
rated on a 7-point Likert scale (1 = Strongly Disagree to 7 = Strongly Agree). The measure looks 
for extreme responses and has a straightforward recoding scheme that converts low responses (1 
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through 3) and high responses (5 through 7) into values between 1 and 3, all other values are 
recoded as 0. Items 1 through 6 map onto the hypermentalization subscale with a minimum 
possible score of 0 and a maximum score of 18. Items 2 and 4 through 8 map onto the 
hypomentalization subscale with a minimum possible score of 0 and a maximum score of 18. A 
sample hypermentalization item is “People’s thoughts are a mystery to me,” and a sample 
hypomentalization item is “I always know what I feel.” As a measure of emotional insight and 
sensitivity to the goals and desires of other people, it has been found to be an important aspect of 
differences in clinical presentation (Fonagy et al., 2016). 
The five-factor instrument used here was collated by DeYoung, Quilty, and Peterson 
(2007). It has a total of 100 items and 40 were selected to equally represent each of the five 
factors and to reduce respondent fatigue. It uses a 5-point Likert scale (1 = Strongly Disagree to 
5 = Strongly Agree) and allocates 8 items to each of the five factors. Examples of each of the 
factors are “I carry out my plans,” (Conscientiousness), “I love to reflect on things” (Openness), 
“I am not interested in other people’s problems” (Agreeableness), “I make friends easily” 
(Extraversion), and “I get angry easily” (Neuroticism). The items for each factor are averaged 
together to get a total score for that factor.  
 
Data analysis plan 
Clinical Outcomes 
Clinical outcomes will be computed for effect size (Cohen’s d), for clinically significant change 
and reliable improvement metrics (following Jacobson & Truax, 1992), for remission criteria 
(scores of 4 or less), and for reduction of cardinal symptoms for depression (depressed mood and 
loss of interest; Kennedy, 2008; Kroenke, Spitzer, & Williams, 2003) and anxiety (nervousness 
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or anxious mood and uncontrollable worry; Kroenke et al., 2007). Number of patients 
experiencing a 50% reduction in symptoms is also reported.   
Relation of Individual Difference Variables to Baseline Severity 
Hierarchical regression predicting baseline severity scores for the GAD-7 and PHQ-9 as the 
dependent variables from scores for the CSI, RFQ, and FFM. Regression and all model testing 
will be conducted in JASP, version 0.12.1.  
Relation of Individual Difference Variables to Outcome 
Hierarchical regression predicting symptoms scores at 3 months for the GAD-7 and PHQ-9 
combined as the dependent variable, controlling for platform usage (specifically, words written 
by the patient and therapist), baseline GAD-7 and PHQ-9 scores, and patient education level in 
step one, then incorporating scores from the CSI, RFQ, and FFM into step 2 to isolate the 
association of individual difference variables on change in symptom measures. Patient education 
and words written are the only demographic and usage variables associated with outcomes on 
this platform to date. Regression and all model testing will be run using JASP, version 0.12.1. 
Effect of Treatment on Individual Difference Variables  
The RFQ and CSI were administered at the beginning of treatment and at 3 months of completed 
treatment. A paired samples t-test will be run to check for general change between pre- and at 3 
months of treatment. Hierarchical regression predicting scores from the RFQ and CSI combined 
at 3 months of treatment as the dependent variable, controlling for platform usage (specifically, 
words written by the patient and therapist), baseline RFQ and CSI scores, and patient education 
in step one, then incorporating change scores from the GAD-7 and PHQ-9 from baseline to 3 
months into step 2 to isolate the association of symptom improvement on the individual 





Of the 237 patients who agree to participate, 130 patients met inclusion criteria and had 
complete scores for GAD-7, PHQ-9, CSI, RFQ and five-factor measures. Patients were between 
the ages of 18 and 65, with the majority (55%) falling between 26-35 years of age. Women were 
63.1% of the patient sample, and 65.4% of patients had Bachelor’s degrees or higher education 
level. There were no difference in baseline measures or demographics between the 130 who 
completed the study and the 107 who started, but did not complete. Table 1 provides the full 
distribution of demographic and clinical characteristics. 
 
Table 1.  
Demographic Characteristics for Full Sample (N=130). 
 
Variable Percentage (N) 
Age:   
18-25 24% (31) 
26-35 55.4% (72) 
36-49 14.9% (19) 
50+ 5.7% (8) 
Education:   
Bachelor Degree or Higher 65.4% (85) 
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High School Diploma or Less 34.6% (45) 
Race/Ethnicity: 
 
            European American 62.3% (81) 
            African American 14.8% (19) 
            Southeast/Asian American 12.0% (16) 
            Native American 0.5% (1) 
              Other 10.4% (13) 
Hispanic/Latinx 12.7% (17) 
Gender:    
Female 63.1% (82) 
Male 30.7% (40) 
[other identity] 6.2% (8) 
Patient’s State:    
California 16.2% (21) 
New York 13.9% (18) 
Washington 4.8% (6) 
New Jersey 4.6% (6) 
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[other U.S. State] 60.5% (79) 
 
 Treatment duration was on average 90.4 days (SD=15.2). At three months of treatment, 
participants reported significantly less depression (M = 7.03, SD = 5.2, t(129) = 5.92, p < .001, d 
= 0.52, 95% CId [0.335, 0.701],), than prior to treatment (M = 9.4, SD = 4.78), and less anxiety 
(M = 7.37, SD = 4.87, t(129) = 6.44, p < .001, d = 0.56, 95% CId [0.378, 0.749],), than prior to 
treatment (M = 10.4, SD = 4.85). Viewed through the framework of reliable and clinically 
significant change (Jacobson & Truax, 1992), 43% of the sample reported PHQ-9 score 
reductions of 5 or more points and fell below the established threshold for probable depression, 
and 51% of the sample reported GAD-7 score decreases of 5 or more points and fell below the 
established threshold for probable anxiety by their last observation. Full remission (defined as 
sum scores of 4 points or less) at 3 months was reported by 30.9% of patients on the GAD-7, and 
33% for the PHQ-9. Average scores for the cardinal symptoms of depression were 4.2 (SD = .82) 
prior to treatment and 2.1 (SD = .51) at three months, with 38% reporting no cardinal depression 
symptoms at three months. Average scores for the cardinal symptoms of anxiety were 4.7 (SD = 
.72) prior to treatment and 2.6 (SD = .43) at three months, with 40% reporting no cardinal 
anxiety symptoms at three months. 
Treatment engagement, as measured by word count, was an average of 475.2 words (SD 
= 784.9) per week of treatment generated by patients and 323.0 (SD = 650.7) by therapists, about 
50% less than the average previously reported for a very large sample of patients on this platform 
(cf. Malgaroli et al, 2020).  
All of the following analyses are based on the full sample and look at change over three 
months of treatment. However, thirty-nine (n = 39, 30% of the full sample) participants 
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continued treatment past the three month mark, averaging a 267 day (SD = 90.4) treatment 
course and reported significantly less depression (M = 7.33, SD = 5.6, t(38) = 2.77, p < .009, d = 
0.44, 95% CId [0.112, 0.771],), than prior to treatment (M = 9.74, SD = 4.34), and less anxiety 
(M = 7.08, SD = 4.70, t(38) = 2.94, p < .006, d = 0.47, 95% CId [0.137, 0.800],), than prior to 
treatment (M = 9.90, SD = 4.84). 
Convergence of Context Sensitivity Measures 
See Table 2 for relationships between the subscales of the RFQ and CSI. The negative 
association previously reported (Fonagy et al., 2016) between the Hypermentalization and 
Hypomentalization subscales was supported, pre-treatment, r(130) = -.685, p<.001), and after 3 
months of treatment, r(130) = -.653, p<.001). Contrary to the positive association between the 
Cue Presence and Cue Absence subscales previously reported (Bonanno et al., 2018), a negative 
correlation was found, pre-treatment, r(130) = -.395, p<.001), and after 3 months of treatment, 
r(130) = -.427, p<.001). The hypothesized inverse relationship between Cue Absence and 
Hypomentalizing, and inverse relationship between Cue Presence and Hypermentalizing were 
not supported (see Table 2). Unexpectedly, there was a small positive association between the 
Cue Absence subscale and Hypermentalization subscale at 3 months of treatment, r(130) = .271, 
p<.002).  
 
Table 2. Relationships between Context Sensitivity Measures 
Pre-Treatment Cue Presence Cue Absence 
   Hypermentalization .062 .014 
   Hypomentalization -.057 -.060 
3 Months Cue Presence Cue Absence 
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   Hypermentalization -.165 .271** 
   Hypomentalization .113 -.103 
Note. *p<.05, **p<.01, ***p<.001 
 
Individual Difference Measures and Baseline Symptoms 
To examine the relationship between context sensitivity and baseline symptoms, we used two 
step hierarchical multiple regression to control for associations with the five-factor personality 
dimensions in step one, while RFQ and CSI subscales were analyzed in step. Depression and 
anxiety symptoms were combined in accordance with the finding that difficulties with context 
sensitivity were not specific to any single diagnostic category (Bonanno et al, 2018). Regression 
statistics are reported in Table 3.  
 
Table 3. Linear model of individual difference predictors of baseline symptom scores. 
 b SE r sr2 R R2 
Step 1     .424 .180 
Constant  11.8     
  Extraversion -.162 .138 -.152 .026   
  Conscientiousness -.077 .192 -.132 .007   
  Openness .287** .213 .129 .075   
  Agreeableness .084 .251 .127 .008   
  Neuroticism .322*** .155 .301*** .096   
Step 2     .454 .206 
Constant  11.6     
  Extraversion -.151 .140 -.152 .026   
  Conscientiousness -.082 .197 -.132 .007   
29 
 
  Openness .289** .221 .129 .078   
  Agreeableness .100 .262 .127 .010   
  Neuroticism .241* .175 .301*** .049   
  Cue Presence .035 .082 .085 .002   
  Cue Absence -.080 .133 -.083 .003   
  Hypermentalization -.079 .236 -.203* .003   
  Hypomentalization .098 .258 .223* .006   
*p < .05, ** p < .01, *** p < .001 
The regression model at step one reflects previously documented associations between the five-
factor traits and symptom scores, F(5,124) = 5.44, p<.001, with Extraversion negatively 
associated and Neuroticism positively associated. Greater Openness scores were also associated 
with greater baseline symptoms. When the four context sensitivity measures were included in 
step two, none were significant predictors of baseline symptom scores.  
 
Individual Difference Measures and Symptom Improvement 
To examine the relationship between context sensitivity and symptom improvement resulting 
from treatment, we used three step hierarchical multiple regression to control for associations 
between words written by the client and baseline symptoms in step one, with RFQ and CSI 
scores in step two, and possible interactions in step three. All variables were centered prior to 
analysis to ensure low multicollinearity. The five-factor dimensions were not included as they 
were not a focus of this study. Initial analyses also suggested that obtained education, which 
previous work associated with symptom improvement, was not associated with symptom 
improvement in this sample (r(130) = .013, p = .860) and was thus not included in the model. 
The forward method was used in step three to identify significant interactions. Regression 




Table 4. Linear model of individual difference predictors of final symptom scores. 
 b SE r sr2 R R2 
Step 1     .530 .281 
Constant  1.814     
  Client Words Written -.141 <.001 -.158 .027   
  Baseline Symptom Scores .506*** .045 .511*** .262   
Step 2     .567 .322 
Constant  1.836     
  Client Words Written -.147* <.001 -.158 .030   
  Baseline Symptom Scores .457*** .084 .511*** .224   
  Cue Presence -.006 .080 .020 <.001   
  Cue Absence -.050 .118 -.079 .003   
  Hypermentalization -.157 .223 -.288*** .019   
  Hypomentalization .057 .250 .272** .003   
Step 3     .593 .352 
Constant  1.841     
  Client Words Written -.155* <.001 -.158 .035   
  Baseline Symptom Scores .482*** .083 .511*** .247   
  Cue Presence -.002 .079 .020 <.001   
  Cue Absence -.058 .116 -.079 .004   
  Hypermentalization -.199* .223 -.288*** .030   
  Hypomentalization .019 .248 .272** <.001   
  Hyperment X Baseline Sxs -.179* .018 -.079 .045   
 *p < .05, ** p < .01, *** p < .001 
The regression model at step one reflects previously documented associations between client 
activity measured by number of words written and lower symptom scores after 3 Months of 
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treatment, F(5,124) = 9.72, p<.001. When the four context sensitivity measures were included in 
step two, none were significant predictors of 3 month symptom scores. An interaction detected in 
step three suggested that for individuals (n=34) with low hypermentalization scores (z-score>-1), 
having higher baseline symptoms led to higher 3 month symptoms, b = .110, t = 2.35, p = .021 
(See Figure 1). Simple slope effects for average and high values of hypermentalization were not 
significant (p > .05).  
 
Figure 1. Interaction between Pre-treatment and 3 Month Symptoms by level of Baseline 
Hypermentalization 
 
Note: Plotted lines reflect three levels, one for scores a standard deviation or more below the 
mean (green), another for scores between -1 and 1 standard deviation around the mean (tan), and 





Effect of Treatment on Individual Difference Variables 
Predicting Final Cue Presence Score 
To examine the relationship of treatment on changes in Cue Presence scores, we used three step 
hierarchical multiple regression to control for associations between pre-treatment Cue Presence 
scores in step one, with pre-treatment symptom scores and change in symptoms scores after 3 
months of treatment in step two, and the interaction between pre-treatment symptom severity and 
change in symptom scores in step three. All variables were centered prior to analysis to ensure 
low multicollinearity. Regression statistics are reported in Table 5.  
 
Table 5. Linear model of symptom improvement predicting 3 Month Cue Presence. 
 b SE r sr2 R R2 
Step 1     .545 .297 
Constant  .627     
  Cue Presence Baseline .545*** .065 .545*** .297   
Step 2     .547 .299 
Constant  .631     
  Cue Presence Baseline .547*** .065 .545*** .296   
  Baseline Symptoms .020 .081 .045 <.001   
  Symptom Change -.051 .078 -.009 .002   
Step 3     .554 .307 
Constant  .633     
  Cue Presence Baseline .539*** .066 .545*** .286   
  Baseline Symptoms .009 .081 .045 <.001   
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  Symptom Change .017 .094 -.009 <.001   
  Baseline Sxs X Sxs 
Change 
-.110 .009 -.120 .008   
*p < .05, ** p < .01, *** p < .001 
The regression model at step one reflects the expected association between pre- and 3 month 
scores for any repeated measure, F(1,128) = 17.95, p<.001. When baseline symptom severity and 
symptom improvement between pre- and 3 month scores were included in step two, none were 
significant predictors of 3 month Cue Presence scores. The interaction between baseline 
symptom severity and degree of symptom improvement pre- to 3 month scores was not a 
significant predictor of 3 month Cue Presence scores.   
 
Predicting Final Cue Absence Score 
To examine the relationship of treatment on changes in Cue Absence scores, we used three step 
hierarchical multiple regression to control for associations between pre-treatment Cue Absence 
scores in step one, with pre-treatment symptom scores and change in symptoms scores at 3 
months in step two, and the interaction between pre-treatment symptom severity and change in 
symptom scores in step three. All variables were centered prior to analysis to ensure low 
multicollinearity. Regression statistics are reported in Table 6. 
 
Table 6. Linear model of symptom improvement predicting 3 Month Cue Absence. 
 b SE r sr2 R R2 
Step 1     .409 .167 
Constant  .564     
  Cue Absence Baseline .409*** .086 .409*** .167   
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Step 2     .434 .189 
Constant  4.389     
  Cue Absence Baseline .409*** .086 .409*** .166   
  Baseline Symptoms .008 .072 .035 <.001   
  Symptom Change .143 .069 .148 .017   
Step 3     .436 .190 
  Cue Absence Baseline .409*** .087 .409*** .166   
  Baseline Symptoms .013 .073 .035 <.001   
  Symptom Change .115 .084 .148 .007   
 Baseline Sxs X Sxs 
Change 
.046 .008 .116 .001   
*p < .05, ** p < .01, *** p < .001 
The regression model at step one reflects the expected association between pre- and 3 month 
scores for any repeated measure, F(1,128) = 9.76, p<.001. When baseline symptom severity and 
symptom improvement between pre- and 3 months were included in step two, none were 
significant predictors of 3 month Cue Absence scores. The interaction between baseline 
symptom severity and degree of symptom improvement pre- to 3 months was not a significant 
predictor of 3 month Cue Absence scores. 
 
Predicting Final Hypermentalization Score 
To examine the relationship of treatment on changes in Hypermentalization scores, we used three 
step hierarchical multiple regression to control for associations between pre-treatment 
Hypermentalization scores in step one, with pre-treatment symptom scores and change in 
symptoms scores at 3 months in step two, and the interaction between pre-treatment symptom 
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severity and change in symptom scores in step three. All variables were centered prior to analysis 
to ensure low multicollinearity. Regression statistics are reported in Table 7. 
 
Table 7. Linear model of symptom improvement predicting 3 month Hypermentalization. 
 b SE r sr2 R R2 
Step 1     .702 .493 
Constant  .265     
  Hyperment. Baseline .702*** .061 .702*** .492   
Step 2     .717 .515 
Constant  .462     
  Hyperment. Baseline .670*** .064 .702*** .408   
  Baseline Symptoms -.071 .035 -.135 .004   
  Symptom Change .168* .033 .210* .022   
Step 3     .717 .515 
  Hyperment. Baseline .670*** .064 .702*** .399   
  Baseline Symptoms -.071 .035 -.135 .004   
  Symptom Change .170* .039 .210* .016   
 Baseline Sxs X Sxs 
Change 
-.003 .004 .220* >.001   
*p < .05, ** p < .01, *** p < .001 
The regression model at step one reflects the expected association between pre- and 3 month 
scores for any repeated measure, F(1,128) = 124.25, p<.001. When baseline symptom severity 
and symptom improvement between pre- and 3 months were included in step two, Symptom 
Change was a significant predictor of 3 month Hypermentalization scores. The interaction 
between baseline symptom severity and degree of symptom improvement pre- to 3 months was 




An alternative approach was also used that avoided the use of change scores when predicting 
change in Hypermentalization over time (see Table 8). This alternative used the residuals from 
Step 1 of the regression equation for predicting symptom outcome at 3 months (See Table 4, 
Step 1).  
 
Table 8. Linear model of symptom improvement predicting 3 month Hypermentalization. 
 b SE B r sr2 R R2 
Step 1     .702 .493 
Constant  .265     
  Hyperment. Baseline .702*** .061 .702*** .493   
Step 2     .719 .516 
Constant  .260     
  Hyperment. Baseline .667*** .061 .702*** .423   
  Residuals -.083** .033 .-.306*** .024   
 
Predicting Final Hypomentalization Score 
To examine the relationship of treatment on changes in Hypomentalization scores, we used three 
step hierarchical multiple regression to control for associations between pre-treatment 
Hypomentalization scores in step one, with pre-treatment symptom scores and change in 
symptoms scores at 3 months in step two, and the interaction between pre-treatment symptom 
severity and change in symptom scores in step three. All variables were centered prior to analysis 
to ensure low multicollinearity. Regression statistics are reported in Table 9. 
 
Table 9. Linear model of symptom improvement predicting 3 month Hypomentalization. 
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 b SE B r sr2 R R2 
Step 1     .645 .416 
Constant  .263     
  Hypoment. Baseline .645*** .067 .645*** .416   
Step 2     .677 .458 
Constant  .255     
  Hypoment. Baseline .588*** .068 .645*** .317   
  Baseline Symptoms .192** .034 .236** .028   
  Symptom Change -.203** .032 -.164* .033   
Step 3     .687 .472 
  Hypoment. Baseline .567*** .069 .645*** .287   
  Baseline Symptoms .183** .034 .236** .025   
  Symptom Change -1.116 .038 -.164* .007   
 Baseline Sxs X Sxs 
Change 
-.149* .004 -.298*** .014   
*p < .05, ** p < .01, *** p < .001 
 
The regression model at step one reflects the expected association between pre- and 3 month 
scores for any repeated measure, F(1,128) = 91.22, p<.001. When baseline symptom severity and 
symptom improvement between pre- and 3 months were included in step two, both were 
significant predictors of 3 month Hypomentalization scores in the expected direction. The 
interaction between baseline symptom severity and degree of symptom improvement pre- to 3 
months was trending to predict final Hypomentalization scores and explained a statistically 
significant, though small proportion of variance in 3 month Hypomentalization scores, DR2 = 
.014, F(4, 125) = 27.96, p < .001. The interaction suggested that individuals (n=24) reporting the 
most symptom improvement (z-score>1) pre-treatment to 3 months had lower 3 month 
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Hypomentalization scores, b = -.278, t = -1.35, p = .012 (See Figure 2). Simple slope effects for 
average and low values of symptom change were not significant (p > .10). To make the 
interaction easier to see, an additional graph was generated including only the two largest 
classes, mean scores and scores greater than one standard deviations above the mean (See Figure 
3).  
Figure 2. Interaction between Pre-treatment Hypomentalization and 3 Month Hypomentalization 
by all three levels of Symptom change 
 
Note: Plotted lines reflect three levels, one for scores a standard deviation or more below the 
mean (green), another for scores between -1 and 1 standard deviation around the mean (tan), and 





Figure 3. Interaction between Pre-treatment Hypomentalization and 3 Month Hypomentalization 
with two levels of Symptom change 
 
Note: Plotted lines reflect two levels, one for scores between -1 and 1 standard deviation around 
the mean (tan), and a second for scores a standard deviation above the mean (grey). 
 
An alternative approach was also used that avoided the use of change scores when predicting 
change in individual difference variables (see Table 10). This alternative used the residuals from 
Step 1 of the regression equation for predicting symptom outcome at 3 months (See Table 4, 
Step 1).  
 
Table 10. Linear model of symptom improvement predicting 3 month Hypomentalization. 
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 b SE B r sr2 R R2 
Step 1     .645 .416 
Constant  .263     
  Hypoment. Baseline .645*** .067 .645*** .416   
Step 2     .669 .447 
Constant  .255     
  Hypoment. Baseline .611*** .067 .645*** .361   






 Individual differences in emotion regulation may be an important route for explaining the 
finding that much of outcome in psychotherapy is accounted for by characteristics that patients 
bring with them to the treatment setting. In beginning to explore the impact of emotion 
regulation abilities on treatment outcome, we focused on context sensitivity as an important first 
step in the emotion regulation (Bonanno & Burton, 2013) process that may have a significant 
relationship with pre-treatment severity and 3-month improvement. We selected two instruments, 
the Context Sensitivity Index (CSI; Bonanno, Maccallum, Malgaroli, & Hou, 2020) and the 
Reflective Functioning Questionnaire (RFQ; Fonagy et al., 2016) to capture multiple aspects of 
context sensitivity that could be easily distributed to individuals receiving care on a digital 
therapy platform. Finally, emotion regulation is a common target of psychotherapy and may 
influence therapy effects while also being influenced by successful therapy. We designed 
instrument deployment to match the timing of context sensitivity measures with symptom scales 
to look for changes in clinical and emotion regulation constructs pre- and at 3 months of 
treatment.  
 In this study, we found half of the sample reported clinically significant change and about 
40% reported no cardinal symptoms and full remission at 3 months with symptom scores less 
than five. The expected convergent relationship between the RFQ and CSI was not detected. 
Higher Openness and Neuroticism scores were associated with greater symptom severity at 
baseline, however we did not find the hypothesized association between higher baseline severity 
and either poor reflective functioning or lower context sensitivity.  
 In turning to reflective functioning and context sensitivity as indicators of outcome in 
digital psychotherapy, we found an unexpected association between baseline lower 
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Hypermentalization and worse outcomes at 3 months. No other baseline scales for context 
sensitivity or reflective functioning were associated with outcomes at 3 months. We also 
expected greater symptom improvement to be associated with improvements in context 
sensitivity and reflective functioning. While we did not find an association between context 
sensitivity reported at 3 months and symptom improvement, associations were found for both 
reflective functioning constructs. Specifically, greater symptom improvement was surprisingly 
associated with worse hypermentalization at 3 months, whereas greater symptom improvements 
were associated with improved hypomentalization, especially when baseline symptoms were 
high.  
 Results for symptom measures support previous findings on the effectiveness of the 
digital platform for reducing symptoms among individuals presenting with depression and 
anxiety diagnoses (DellaCrosse, Mahan, & Hull, 2018; Hull & Mahan, 2017; Malgaroli, Hull, 
Connolly, Feuerstein, & Simon, 2020). The association between the number of words written by 
the patient as part of the treatment and improvement was also found in this sample, congruent 
with previous work, though overall engagement, as measured by word count, was about 40% 
lower than has been previously reported (Malgaroli, Hull, Connolly, Feuerstein, & Simon, 2020). 
One possible explanation is that many of the participants began treatment right before or around 
the beginning of the novel coronavirus disease 2019 (COVID-19) pandemic as it was being 
addressed by physical distancing and shutdown measures in the United States. The significant 
adjustment required during this time may have made it difficult to engage with treatment as seen 
previously. 
 Previous work has found associations between both context sensitivity and depression 
and anxiety (Bonanno, Maccallum, Malgaroli, & Hou, 2020), and reflective functioning and 
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depression and anxiety (Fonagy et al., 2016). Context sensitivity and reflective functioning also 
share a theoretical interest in how individuals attend to cues in the environment that are relevant 
for self-regulation. We therefore expected some modest overlap between the subscales of the CSI 
and RFQ, which measure these constructs. In looking specifically at the subscales of each 
measure, we predicted that the Cue Presence aspect of the CSI would be negatively correlated 
with Hypermentalization, given that Cue Presence reflects accurate identification of cues in a 
context, whereas Hypermentalization is the imposition of assumptions on a context by the 
individual. Similarly, we expected that Cue Absence would be inversely related to 
Hypomentalization since Cue Absence is the recognition that needed interpretive information is 
missing, whereas Hypomentalization reflects uncertainty regarding one’s own feelings and the 
feelings of others. Cue Absence and Hypomentalization were also previously associated with 
symptoms of depression and anxiety. Contrary to expectations, these postulated aspects of 
context sensitivity bore no relationship to each other. Instead, a small and unexpected 
relationship between Cue Absence and Hypermentalization was found only for the second 
administration at 3 months of treatment, though when making the appropriate adjustments for 
multiple comparisons, this association appears to be spurious.  
A critical question is why these measures did not converge as expected. One possibility is 
that the CSI measures the outcomes of an implicit judgment process by asking respondents to 
give ratings of their sense of control, urgency, and cooperation in the given context. It does not 
ask about the judgment process itself. For example, whether they missed a social cue, assumed 
an erroneous social cue, or failed to account for aspects of their emotional reaction to a feature of 
the context. This is one reason why performance-based measures like the CSI must be evaluated 
against norms for how people tend to respond. While this offers the advantages of performative 
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measures, such that items are causal indicators instead of effect indicators (cf. Bonanno, 
Maccallum, Malgaroli, & Hou, 2020), it leaves the concrete details of the performance itself 
unspecified. In other words, the CSI can tell you how well someone performed relative to 
empirically derived norms, but it cannot tell you how or why they performed the way they did. 
Since the types of cues relevant for successful CSI performance are unknown, it is difficult to 
determine a priori when an instrument measuring particular cues will be associated with CSI 
performance. It could be that the RFQ identifies cues that are simply unrelated to the ways in 
which people make judgments of the CSI scenarios, even if they could be thought of as 
potentially relevant contextual cues on their face. Identifying convergent measures that specify 
particular cue types offers an intriguing possibility for future research into how judgments of CSI 
scenarios are made.  
 Another possible reason the CSI and RFQ were unrelated is that the CSI is designed to 
measure reactions to stressors, whereas the RFQ is a more global measure of how well 
individuals are able to evaluate their own feelings and the thoughts of others. The domain of 
application may be separate enough that even though both have been associated with depression 
and anxiety, they are associated with these symptoms in very different ways. The RFQ reflects 
one’s understanding of and the ability to report on general dispositions of how they relate to 
themselves and to others. Whereas CSI scores reflect one’s implicit formation of judgments 
related to control, urgency, and cooperation for given stressful scenarios. Perhaps the 
dispositions of the RFQ have little bearing on one’s sense of control, urgency, or cooperation 
when facing a stressor.  
We also found a relatively strong inverse relationship between Cue Presence and Cue 
Absence, contrary to the positive relationship previously reported. This difference may be 
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another reason for the lack of relationship between CSI and RFQ measures. There was no 
evidence of monotonic responding in the CSI responses, nor any for unusually extreme sum 
scores. This is the first time that the CSI has been deployed among a clinical, treatment seeking 
population and may pull for different types of responses than for the population it was normed 
on. As alluded to above, stressors may be a more common contributor to reported depression and 
anxiety symptoms for a nonclinical population than for a clinical one and this may pull the 
intuitions of CSI respondents in different ways. Another possibility is that this sample reported 
higher than usual Hypermentalization scores, suggesting that this sample has a greater tendency 
to attribute unambiguous mental states to others than is usual. Indeed, Hypermentalization scores 
in this sample are double that reported in Fonagy et al (2016) and this may have led participants 
to make more unusual judgments on the CSI than seen previously.   
 When looking at associations between individual differences and baseline symptom 
severity, we found the expected relationships between Extraversion and lower baseline 
symptoms, and Neuroticism and higher baseline symptoms. The positive association between 
Openness and greater symptom severity is the opposite of that typically reported (Bleidorn et al., 
2019). Several Openness items ask about interest in activities involving travel, going to public 
places, or seeking stimulation outside of the home. It is possible that COVID-19 restrictions may 
impact individuals with these kinds of interests more than others, which could be driving this 
association. It could also be that individuals with higher Openness are attracted to the platform, 
given the novel nature of this type of treatment, and so are more represented among this sample. 
CSI and RFQ scores were not associated with baseline symptom severity, contrary to 
expectations. This remained true even when removing the five-factor dimensions from the 
model. This lack of replication may reflect a difference in measuring participant dispositions at 
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the beginning of treatment rather than in the course of daily living. The decision to enter 
treatment is a combination of one’s history with depression and anxiety, the timing of factors in 
one’s living situation and recent, acute events (Pescosolido, Gardner, & Lubell, 1998; Jameson 
& Robert, 2010). These additional factors may contribute to baseline symptom scores far beyond 
factors of emotion regulation and context sensitivity. Controlling for an individual’s 
circumstance upon entering treatment may help to isolate the contribution of context sensitivity 
and reflective functioning relative to baseline symptoms in future research.  
 In analyzing the association between RFQ scores and treatment outcome, lower 
Hypermentalization was related to worse outcomes, with an interaction suggesting that when 
Hypermentalization was low, 3 month symptoms were more likely to be high when baseline 
symptoms were high. In addition, the residual model suggested that symptom improvement was 
associated with worsening Hypermentalization. This is not easy to account for given that higher 
Hypermentalization has been previously associated with greater psychopathology (Fonagy et at., 
2016). Since those with low Hypermentalization in this sample were the least likely to improve, 
it may be that the therapeutic relationship was especially important for individuals reporting high 
levels of Hypermentalization. However, individuals with high Hypermentalization typically 
struggle to relate to others or utilize relationships effectively. Perhaps the messaging platform 
provides additional social distance from the therapist and this enables these patients to make 
more progress or stick with therapy compared to face-to-face settings. Another possibility is that 
by reducing depression and anxiety symptoms, troubling hypermentalization tendencies come 
more to the fore for patients. Further research is needed to fully understand this association. 
 Results for the relationship between symptom reduction in treatment and changes in RFQ 
scores suggest that Hypomentalization is the most malleable of the constructs, especially when 
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baseline symptoms are more severe and the patient experiences more change in treatment. This 
supports the previously reported association between Hypomentalization and depression and 
anxiety symptoms, but goes further in suggesting that therapy may serve to increase one’s ability 
to be aware of one’s own feelings and thoughts, as well as the feelings and thoughts of others as 
measured by the Hypomentalization subscale. Virtually every form of psychotherapy seeks to 
improve these capacities (Cuijpers, Reijnders, & Huibers, 2019). Nevertheless, the relationship is 
not a straightforward one, only being present in the extremes. This raises two possibilities. One, 
that focusing on cognitive and emotion awareness is especially important for individuals with 
severe depression and anxiety, and two, that the Hypomentalization measure simply lacks 
sensitivity when cases are less severe. Future research utilizing therapy process measures like 
hand coded rubrics or natural language processing might be able to better determine the true 
utility of awareness practices on outcome and changes in Hypomentalization.  
 Lastly, a critical question is why the CSI did not bear any of the expected associations. 
We have offered several specific possibilities above, including clinical sample, unusually high 
presence of Hypermentalization, the complex factors that bring individuals to treatment over 
those reporting depression and anxiety symptoms in a community sample, and the possibility that 
context sensitivity may change slowly, if at all, in response to treatment. An additional general 
consideration is that context sensitivity on its own may be insufficient for determining the role of 
emotion regulation in psychotherapy. The Regulatory Flexibility approach (Bonanno & Burton, 
2013) identifies two additional processes, repertoire and feedback, as equally important in 
understanding how emotion regulation events unfold. It is possible that strengths in one’s 
repertoire or ability to adjust to feedback may make up for weaknesses in context sensitivity or 
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that individuals have other ways of compensating that make isolating context sensitivity as an 




Limitations and Future Directions 
 While our findings support previously reported clinical outcomes, engagement metrics, 
and some relationship between RFQ scores and outcome, there are limitations to this study. First, 
investigating individual differences with a sample of this size severely limits the power of the 
analyses and may leave certain associations unidentified while exaggerating the influence of 
others. In addition, the exploratory nature of the analyses will tend to capitalize on multiple 
comparisons. For example, the weak, but statistically significant association between Cue 
Absence and Hypermentalization at 3 months was neither predicted from theory nor from 
previous empirical work. The association between Openness and baseline symptoms is similar. If 
p values were corrected for multiple comparisons in that case, it would no longer be significant. 
This limitation may also apply to the regression models conducted, especially where effects were 
the reverse of those expected, such as lower Hypermentalization scores predicting greater 
symptoms at 3 months. Finally, the unique historical event of COVID-19 emerged halfway 
through recruitment of participants into this study. It is difficult to fully account for the impact of 
this event on the findings, except to note that engagement was lower than typical, and that the 
study had to be prematurely concluded to enable the digital platform to adjust to increased 
demand and greater severity of cases presenting for care (Hull et al., 2021). As a result of these 
limitations, it may be premature to make determinations regarding whether the measures of 
context sensitivity employed here have utility in accounting for important patient characteristics 
in psychotherapy or not. Future research utilizing the advantages of digital platforms for 
recruiting larger samples will be important for furthering investigating the impact of individual 
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Table 11. Associations between Gender, Symptom Severity, and Individual Differences 
Score Female (n = 82) Male (n = 13) Other (n = 8) 
Symptoms    
Baseline Symptoms  19.0 (9.1) 22.4 (9.9) 22.1 (4.9) 
3 Month Symptoms 13.5 (9.5) 11.5 (6.6) 19.0 (10.8) 
CSI    
Baseline Cue Pres 51.6 (9.8) 51.5 (10.1) 53.0 (9.7) 
3 Month Cue Pres 52.9 (8.4) 56.7 (9.9) 56.6 (8.1) 
    
Baseline Cue Abs 50.1 (6.8) 53.2 (5.3) 46.9 (5.1) 
3 Month Cue Abs 50.3 (7.1) 50.5 (8.7) 47.4 (7.1) 
RFQ    
Baseline Hyperm. 6.1 (4.7) 5.4 (4.1) 3.8 (2.1) 
3 Month Hyperm. 6.1 (4.4) 5.8 (4.1) 3.3 (3.2) 
    
Baseline Hypom. 4.1 (4.2) 3.23 (4.3) 4.8 (3.4) 
3 Month Hypom. 3.8 (3.9) 2.8 (3.3) 6.0 (3.9) 
 
